Abstract
Get full access to this article
View all access options for this article.
References
1.<800> Hazardous Drugs – Handling in Healthcare Settings. United States Pharmacopoeia Web Site. http://www.usp.org/sites/default/files/usp_pdf/EN/m7808.pdf. Accessed August 8, 2014.
2.
Kienle P.C.
New proposed USP <800>: Hazardous drugs handling . PharmPurchasingProducts. 2014 ; 11 (5 ): 34 .
3.
Power L.A.
Kastango E.S.
Douglass K.
Kienle P.C.
Understanding the new proposed USP chapter <800> . Pharm Purchasing Products. 2014 ; 11 (6 ): 6 .
4.Occupational exposure to antineoplastic agents. Centers for Disease Control and Prevention Web Site. http://www.cdc.gov/niosh/topics/antineoplastic/nioshpubs.html. Accessed August 8, 2014.
5.NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2012. Centers for Disease Control and Prevention Web Site. http://www.cdc.gov/niosh/docs/2012-150/. Accessed August 8, 2014.
6.Who enforces compliance with USP <797>? Society of Nuclear Medicine and Molecular Imaging Web Site. http://interactive.snm.org/index.cfm?PageID=7897. Accessed August 8, 2014.
7.AB-1202 occupational safety and health standards: Hazardous drugs. California legislative information Web Site. http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201320140AB1202. Accessed August 8, 2014.